Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Mukhtar AB, Morgan HJ, Gibbs A, Davies GE, et al. Br J Dermatol 2024 Jan 30:ljad502. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mukhtar AB, Morgan HJ, Gibbs A, Davies GE, et al. Targeting CD20-expressing malignant melanoma cells augments BRAF inhibitor killing. Br J Dermatol 2024 Jan 30:ljad502. doi: 10.1093.
PMID: 38288865